Janus Henderson Group
BPMC

Janus Henderson Group’s Blueprint Medicines BPMC Stock Holding History

Janus Henderson Group’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-268,928
Closed -$34.5M – 2410
2025
Q2 		$34.5M Buy
268,928
+240,179
+835% +$24.9M 0.02% 462
2025
Q1 		$2.55M Hold
28,749
– – ﹤0.01% 1160
2024
Q4 		$2.51M Hold
28,749
– – ﹤0.01% 1202
2024
Q3 		$2.66M Hold
28,749
– – ﹤0.01% 1167
2024
Q2 		$3.1M Sell
28,749
-308
-1% -$30.8K ﹤0.01% 1050
2024
Q1 		$2.75M Sell
29,057
-1
-0% -$86 ﹤0.01% 1135
2023
Q4 		$2.68M Sell
29,058
-44
-0.2% -$2.85K ﹤0.01% 1092
2023
Q3 		$1.46M Buy
29,102
+4
+0% +$214 ﹤0.01% 1349
2023
Q2 		$1.84M Buy
29,098
+5,667
+24% +$308K ﹤0.01% 1291
2023
Q1 		$1.05M Buy
23,431
+12,221
+109% +$551K ﹤0.01% 1600
2022
Q4 		$491K Sell
11,210
-11,210
-50% -$538K ﹤0.01% 1726
2022
Q3 		$1.48M Buy
22,420
+11,234
+100% +$722K ﹤0.01% 1446
2022
Q2 		$565K Sell
11,186
-17
-0.2% -$996 ﹤0.01% 1696
2022
Q1 		$716K Buy
11,203
+3
+0% +$215 ﹤0.01% 1687
2021
Q4 		$1.2M Buy
11,200
+5,637
+101% +$590K ﹤0.01% 1436
2021
Q3 		$572K Buy
+5,563
New +$518K ﹤0.01% 1551
2018
Q1 		– Sell
-15,000
Closed -$1.13M – 1361
2017
Q4 		$1.13M Buy
+15,000
New +$1.06M ﹤0.01% 1168
2017
Q2 		– Sell
-30,000
Closed -$1.2M – 1309
2017
Q1 		$1.2M Buy
+30,000
New +$1.07M 0.01% 637

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janus Henderson Group's BPMC Position: Q3 2025 in Review

Janus Henderson Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 268,928 shares — an estimated $34.5M sold.

Janus Henderson Group first reported a position in BPMC in Q1 2017 and held it in 18 quarters. The position peaked at $34.5M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Janus Henderson Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Janus Henderson Group sold 268,928 Blueprint Medicines shares in Q3 2025, an estimated $34.5M.
  • Janus Henderson Group first reported a position in Blueprint Medicines in Q1 2017 and held it in 18 quarters.
  • Janus Henderson Group's Blueprint Medicines position peaked at $34.5M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Janus Henderson Group's 13F filing for Q3 2025, filed 14 Nov 2025.